Navigation Links
Onyx Pharmaceuticals Reports Second Quarter and Six-Month 2008 Financial Results
Date:8/5/2008

,021)

Provision (benefit) for income taxes (60) - 249 -

------ ------ ------ ------

Net income (loss) $4,474 $(10,826) $19,892 $(23,021)

------ ------ ------ ------

Net income (loss) per share:

Basic $0.08 $(0.22) $0.36 $(0.49)

------ ------- ------ -------

Diluted $0.08 $(0.22) $0.35 $(0.49)

------ ------- ------ -------

Shares used in computing net income

(loss) per share:

Basic 55,675 48,242 55,531 47,265

------ ------ ------ ------

Diluted 56,472 48,242 56,534 47,265

------ ------ ------ ------

(1) Includes employee stock-based

compensation charges of:

Research and development $809 $734 $1,389 $1,261

Selling, general, and

administrative 3,444 2,900 8,080 5,365

------ ------ ------ ------

$4,253 $3,634 $9,469 $6,626

------ ------ ------ ------

ONYX PHARMACEUTICALS, INC.

CALCULATION OF NET REVENUE FROM UNCONSOLIDATED JOINT BUSINESS

(In thousands, unaudited)

Three Months Ended Six Months Ended

------------------ ----------------

Jun. 30, Jun. 3
'/>"/>

SOURCE Onyx Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10

Related biology technology :

1. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
2. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
3. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
4. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
5. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
6. Nabi Biopharmaceuticals to Present at Upcoming Industry Conferences
7. Anadys Pharmaceuticals Appoints Steve Worland, Ph.D. as President and Chief Executive Officer
8. Poniard Pharmaceuticals Announces Participation in Upcoming Conferences
9. NovaQuest Advances Virtual Development Model With Strategic Investment in TOPIGEN Pharmaceuticals
10. Drug Royalty Corporation (DRC) Announces Acquisition Regarding PEG-INTRON(R) From Enzon Pharmaceuticals, Inc. (ENZN)
11. Sunesis Pharmaceuticals Announces Reorganization to Focus Resources and Build Value in Clinical-Stage Programs

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...lth care employment grew by 29,000 jobs in Octobe...istent growth during the U.S. recession. However, ... and health systems are coming closer to having to...dministrators. , (Vocus) ...ued growing in October despite the shedding of job...
(Date:11/24/2009)... Nov. 24 /PRNewswire-Asia/ -- Shanghai Biolaxy ann...ation (SFDA) has approved the,investigational new ...t,(Nodlin), an innovative insulin formulation to t... initiate its first phase I clinical study. ,... blood glucose and poor,metabolism. The complicati...
(Date:11/24/2009)..., TORONTO, Nov. 24 /PRNewswire-FirstCall/ - H... Capital Inc., a leading provider of advanced lase...ch and fertility clinic markets, today reported op...ter ended September 30, 2009. , , Q3 2009 High... with $1.43 million in Q3 2008, - Gross profi...
(Date:11/24/2009).../PRNewswire/--HealthRoboticstodayannounced,thatith...ed,investors.ThisrecentlyformedToronto-basedcompan...andwillmarket,install,andsupport,HealthRobotics,i....onaryproductofferingsi.v.STATION(TM),i.v.SOFT(TM),...eassistanceonan"asneeded,basis"toitsstrategicpartn...
Breaking Biology Technology:The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 4Biolaxy Secures IND Approval for Oral Insulin 2Hamilton Thorne announces third quarter results 2Hamilton Thorne announces third quarter results 3Hamilton Thorne announces third quarter results 4Hamilton Thorne announces third quarter results 5Hamilton Thorne announces third quarter results 6Hamilton Thorne announces third quarter results 7Hamilton Thorne announces third quarter results 8Hamilton Thorne announces third quarter results 9Hamilton Thorne announces third quarter results 10Health Robotics Continues its Global Expansion With December 09 ASHP's Launch of Joint Venture in Canada 2
...icals Inc.,(RPI), a wholly owned subsidiary of Ran...at RLL has received tentative approval from the U....agnesium Delayed-Release,Capsules, 20 mg (base) an...cond largest selling drug in the U.S. with total a...cember 2007)., Ranbaxy believes that it has a FTF...
...ceuticals Ltd. (Nasdaq: XTLB ; TASE: XTL) announc...cutive Officer, is scheduled to present at,the 10t...r will present an,overview of the Company includin...tage clinical compound for the treatment of diabet...ll take place on Wednesday, February 13,2008 at 1:...
... ,Human Genome Sciences, Inc. (Nasdaq: HGSI ) and...ement under which Xencor will apply its proprietar...ies to enhance the,pharmacologic properties of mon...lly target antigens discovered by HGS., (Logo: h...O ), "The priority focus of HGS continues to be ...
Other Biology Technology:Ranbaxy Receives Tentative Approval to Manufacture and Market Esomeprazole Magnesium DR Capsules 2XTL Biopharmaceuticals to Present at the 10th Annual BIO CEO & Investor Conference 2Human Genome Sciences and Xencor Announce Antibody Collaboration 2Human Genome Sciences and Xencor Announce Antibody Collaboration 3Human Genome Sciences and Xencor Announce Antibody Collaboration 4
(Date:11/24/2009)... crystallised a protein that may help gut bacteria...ould be used by probiotic producers to identify st...ple. , "Probiotics need to interact with cells li...hey attach to surfaces in the gut they are more li...tivity," says Dr Nathalie Juge from the Institute ...
(Date:11/24/2009)...l action of a remarkable class of ring-shaped prot...the Lawrence Berkeley National Laboratory (Berkele...raphy beamline at the Advanced Light Source (ALS)....xpression and replication, and are vital to the su...ous agents, such as the human papillomavirus, whic...
(Date:11/24/2009)... NEW YORK (November 24, 2009) -- The Wildlife Cons...vealing that the last remaining population of Sibe...to the rising tide of poaching and habitat loss. ,...m Russian officials of what needs to be done to pr... cat. , The report was released by ...
Breaking Biology News(10 mins):A sticky solution for identifying effective probiotics 2Atomic-level snapshot catches protein motor in action 2Atomic-level snapshot catches protein motor in action 3Atomic-level snapshot catches protein motor in action 4Report shows dramatic decline in Siberian tigers 2Now hear this 10478 1Drug Use in Teens May Damage Memory Years Later 59949 1Drug Use in Teens May Damage Memory Years Later 59949 2Time keeping brain neurons discovered 10472 1Time keeping brain neurons discovered 10472 2
...nvolved in embryonic development and cancer, contr...rthritis and osteoarthritis. The article by Nakamu...lyses of Wnt-related genes in human joint disorder...nal of Pathology and is accompanied by a commentar... its disruption can lead to cancer in various orga...
...c recombination, DNA can travel inside an organism...grafting surgery that allows it to insert its chro...rocess is important because mobile DNA can carry g...s that cause disease or tumors that result in cert...surgeons look like that conduct these intricate sn...
...e matters. A team from Brown University and the Ma... a model that explains how viruses and other biopa...n coating called clathrin. , The secret, it seems,...27 to 30 nanometers in diameter, or about 1,000 ti...lular entry. In a research article to be posted th...
Other Biology News:Arthritis: What Wnt wrong? 2Brown-Harvard team solves mobile DNA's surgical sleight-of-hand 2When it comes to cell entry, being average has its advantages 2
Rat Anti-Kinase Suppressor Of Ras Monoclonal Antibody, Unconjugated, Clone MINT/1/4 from GeneTex
Mouse Anti-NY-ESO-1 Monoclonal Antibody, Unconjugated, Clone E978 from Upstate
HRP-STABILPLUS from AbD Serotec
Xylanase Fluorometric (Blue) Assay Kit, EnzChek® from Molecular Probes (Invitrogen)
Biology Products: